A
Agilent Technologies, Inc.NYSEHealthcare$115.48+0.82%ClosedMarket Cap: $32.66B
As of 2026-04-06
Valuation
P/E (TTM)
25.32
PEG
10.28
P/B
4.73
P/S
4.62
EV/EBITDA
18.78
DCF Value
$76.77
FCF Yield
3.0%
Div Yield
0.9%
Margins & Returns
Gross Margin
52.2%
Operating Margin
20.6%
Net Margin
18.3%
ROE
19.7%
ROA
16.3%
ROIC
12.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $1.80B | 52.6% | $353.0M | $305.0M | $1.07 | $0.26 |
| Q4 2025 | $1.86B | 51.8% | $443.0M | $434.0M | $1.53 | $0.25 |
| FY 2025 | $6.95B | 52.4% | $1.48B | $1.30B | $4.57 | $0.99 |
| Q3 2025 | $1.74B | 52.6% | $360.0M | $336.0M | $1.18 | $0.25 |
| Q2 2025 | $1.67B | 51.9% | $300.0M | $215.0M | $0.75 | $0.25 |
| Q1 2025 | $1.68B | 53.5% | $376.0M | $318.0M | $1.11 | $0.25 |
| Q4 2024 | $1.70B | 53.9% | $408.0M | $351.0M | $1.22 | $0.24 |
| FY 2024 | $6.51B | 54.3% | $1.49B | $1.29B | $4.43 | $0.94 |
| Q3 2024 | $1.58B | 54.2% | $333.0M | $282.0M | $0.97 | $0.24 |
| Q2 2024 | $1.57B | 54.4% | $363.0M | $308.0M | $1.05 | $0.24 |
| Q1 2024 | $1.66B | 54.8% | $384.0M | $348.0M | $1.18 | $0.24 |
| Q4 2023 | $1.69B | 54.2% | $408.0M | $475.0M | $1.62 | $0.23 |